Effects of propranolol on tissue necrosis in experimental myocardial infarction in dogs

J Pharmacobiodyn. 1986 Oct;9(10):836-41. doi: 10.1248/bpb1978.9.836.

Abstract

We studied the effects of propranolol on degradation of cardiac structural proteins resulting from ischemia induced by 24 h ligation of the coronary artery in dogs. Degradation of myocardial myosin heavy chain, alpha-actinin and troponin-I was used as an indicator of degradation of cardiac structural proteins. In dogs with left circumflex coronary artery ligation, propranolol, given orally in the dose of 10 or 30 mg/kg, significantly reduced degradation of cardiac structural proteins. This can be supported by the facts that treatment with propranolol, 10 or 30 mg/kg, reduced release of cathepsins B, L and D from lysosome to cytosol in the ischemic tissue and that the reduced acidity of the ischemic tissue was improved by treatment with propranolol, 30 mg/kg. In conclusion, propranlol delays the necrotic development of the severely ischemic myocardial tissue as shown by reduced protein degradation.

MeSH terms

  • Animals
  • Coronary Disease / prevention & control*
  • Dogs
  • Electrophoresis, Polyacrylamide Gel
  • Female
  • Hydrogen-Ion Concentration
  • Male
  • Myocardium / enzymology
  • Myocardium / pathology
  • Necrosis
  • Propranolol / pharmacology*

Substances

  • Propranolol